Henning Mann's Biography

Henning Mann, Senior Research Scientist, Nortis, Inc.

Dr. Mann earned his PhD in physiological chemistry studying the extracellular matrix. As a postdoctoral fellow he worked at the Fred Hutchinson Cancer Research Center in Seattle, WA, where he focused on understanding the function and expression of immuno-stimulatory receptor-ligand pairs. He then studied infectious diseases as a Senior Staff Scientist at Seattle Biomed before joining Nortis, Inc. in 2012. As a Senior Scientist at Nortis, Dr. Mann leads the company's angiogenesis and immuno-oncology efforts.

Tissue Engineered Vascularized Tumor Micro-environments for Preclinical Testing of Anticancer Therapeutics and Toxicology

Friday, 8 July 2016 at 09:30

Add to Calendar ▼2016-07-08 09:30:002016-07-08 10:30:00Europe/LondonTissue Engineered Vascularized Tumor Micro-environments for Preclinical Testing of Anticancer Therapeutics and ToxicologySELECTBIOenquiries@selectbiosciences.com

Nortis provides microfluidic chips for tissue engineering 3D-vascularized tissue micro-environments. Endothelial vessels induced to sprout in response to growth factors create a vascular network that invades tumor tissue. The model can be used to test anticancer therapeutics but can also be applied to the generation of organ-specific vascular and tissue micro-environments.

Add to Calendar ▼2016-07-07 00:00:002016-07-08 00:00:00Europe/LondonOrgans-on-Chips and 3D-Cultures: Technologies and ApproachesSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors